Arcadia Biosciences

Arcadia Biosciences

RKDAPre-clinical

Arcadia Biosciences is an agricultural biotech firm dedicated to improving human health and environmental sustainability through advanced crop science. Its core strategy involves developing proprietary seed traits for crops like wheat, soy, and hemp, with its flagship GoodWheat™ product designed to reduce net carbs and calories while increasing fiber and protein. The company operates as a public entity, commercializing its traits through licensing and direct product sales, and faces the dual challenge of scaling agricultural innovation while navigating complex regulatory and market adoption pathways.

Market Cap
$3.0M
Employees
11-50
Focus
Biotech

RKDA · Stock Price

USD 1.7585.45 (-97.99%)

Historical price data

AI Company Overview

Arcadia Biosciences is an agricultural biotech firm dedicated to improving human health and environmental sustainability through advanced crop science. Its core strategy involves developing proprietary seed traits for crops like wheat, soy, and hemp, with its flagship GoodWheat™ product designed to reduce net carbs and calories while increasing fiber and protein. The company operates as a public entity, commercializing its traits through licensing and direct product sales, and faces the dual challenge of scaling agricultural innovation while navigating complex regulatory and market adoption pathways.

Technology Platform

Proprietary trait development and genome editing platform focused on creating non-GMO crops with enhanced nutritional profiles (e.g., reduced carbs, increased fiber) and agronomic sustainability traits (e.g., water use efficiency).

Funding History

4

Total raised: $150M

IPO$60MUndisclosedFeb 5, 2015
Series C$50MUndisclosedJun 15, 2008
Series B$25MUndisclosedJun 15, 2006
Series A$15MUndisclosedJun 15, 2004

Opportunities

Significant growth opportunities exist in expanding the commercial footprint of GoodWheat™ through new product categories and geographic markets, as well as in securing regulatory approvals for its HB4® Wheat trait, which would unlock a major sustainability-focused product in global wheat markets.
The evolving market for hemp grain, fiber, and cannabinoids presents another potential growth vector.

Risk Factors

Key risks include the company's pre-profitability status and reliance on external financing, the uncertain and lengthy regulatory pathways for novel agricultural traits globally, and the challenge of achieving scale and market adoption for its innovative food ingredients against established commodity competitors.

Competitive Landscape

Arcadia competes with large agricultural biotech firms (Bayer, Corteva) on trait development and with food ingredient companies on product innovation. Its differentiation lies in a dual focus on consumer health (nutrition) and agricultural sustainability, often using non-GMO techniques to develop traits for major food crops.

Company Info

TypePlatform
Founded2002
Employees11-50
LocationDavis, United States
StagePre-clinical
RevenueEarly Revenue

Trading

TickerRKDA
ExchangeNASDAQ

Therapeutic Areas

NutritionMetabolic Health

Partners

Bioceres Crop Solutions (HB4® Wheat License)Various seed distribution partners
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile